Cargando…
Galeterone for the treatment of advanced prostate cancer: the evidence to date
Major advances have been achieved recently in the treatment of metastatic castration-resistant prostate cancer, resulting in significant improvements in quality of life and survival with the use of several new agents, including the next-generation androgen receptor (AR)-targeted drugs abiraterone an...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956059/ https://www.ncbi.nlm.nih.gov/pubmed/27486306 http://dx.doi.org/10.2147/DDDT.S93941 |